X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.


最新的帖子

八月 19, 2020

How are you responding to pharmacopoeia expectation of parenteral preparations?

Regulatory agencies are driving the pharmaceutical industry to continuously improve the quality of drug products, but what is the reality for a drug developer who is expected to make parenteral preparations “practically free from particles”? Expectations of packaging are changing fast but how well prepared is the packaging to meet these needs?
Victoria Morgan

Victoria Morgan

Director, Global Marketing, Biologics

以前的博客
Fluoropolymer

十二月 06, 2019

Advantages of Fluoropolymer-Laminated Components

Candice Sun

Candice Sun

Specialist, Scientific Affairs, CN

Daikyo Crystal Zenith Insert Needle Syringe

七月 10, 2019

Intended Use and Packaging Risks for Compounding Pharmacies (503Bs)

Amy Kim

Amy Kim

Sr. Specialist, Scientific Communications, SA & TS

Load more